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Background: DspA/E is a bacterial type III effector toxic to eukaryotic cells.
Results: Ectopic expression of DspA/E in yeast decreases sphingolipid precursors long chain bases (LCBs) by altering regulation
of serine palmitoyltransferase (SPT).
Conclusion: DspA/E toxicity is linked to LCB depletion.
Significance: Regulation of the sphingolipid pathway is a new cellular process manipulated by a bacterial type III effector.
Erwinia amylovora, the bacterium responsible for fire
blight, relies on a type III secretion system and a single
injected effector, DspA/E, to induce disease in host plants.
DspA/E belongs to the widespread AvrE family of type III
effectors that suppress plant defense responses and promote
bacterial growth following infection. Ectopic expression of
DspA/E in plant or in Saccharomyces cerevisiae is toxic, indi-
cating that DspA/E likely targets a cellular process conserved
between yeast and plant. To unravel the mode of action of
DspA/E, we screened the Euroscarf S. cerevisiae library for
mutants resistant to DspA/E-induced growth arrest. The
most resistant mutants (sur4, fen1, ipt1, skn1, csg1,
csg2, orm1, and orm2) were impaired in the sphingolipid
biosynthetic pathway. Exogenously supplied sphingolipid
precursors such as the long chain bases (LCBs) phytosphin-
gosine and dihydrosphingosine also suppressed the DspA/E-
induced yeast growth defect. Expression of DspA/E in yeast
down-regulated LCB biosynthesis and induced a rapid
decrease in LCB levels, indicating that serine palmitoyltrans-
ferase (SPT), the first and rate-limiting enzyme of the sphin-
golipid biosynthetic pathway, was repressed. SPT down-reg-
ulation was mediated by dephosphorylation and activation of
Orm proteins that negatively regulate SPT. A cdc55 muta-
tion affecting Cdc55-PP2A protein phosphatase activity pre-
vented Orm dephosphorylation and suppressed DspA/E-in-
duced growth arrest.
Sphingolipids comprise a major class of structural materials
and lipid signaling molecules in all eukaryotic cells. Sphingo-
lipid metabolism is generally conserved in animals, yeast, and
plants (1). The major steps of the sphingolipid biosynthesis
have been elucidated in yeast (Fig. 1). The sphingolipid biosyn-
thesis pathway starts with the condensation of a serine with an
acyl-CoA to give long chain bases (LCBs).3 This reaction is cat-
alyzed by the enzyme serine palmitoyltransferase (SPT). The
resulting LCBs are further modified to form ceramides, the
backbone of more complex sphingolipids. Ceramides are then
transported to the Golgi complex where they acquire a species-
specific array of polar headgroups to form the complex sphin-
golipids. Sphingolipid synthesis is tightly regulated. Recent
studies in yeast indicate that this regulation is driven by inhibi-
tion of SPT, the first and rate-limiting enzyme of the sphingo-
lipid pathway. Two yeast homologous proteins, Orm1 and
Orm2, associatewith SPT to inhibit SPT activity. The activity of
Orm proteins is regulated by phosphorylation (2). Orm pro-
teins are inactivated via phosphorylation by the protein kinase
Ypk1 (3, 4), and the Cdc55-PP2A phosphatase was recently
identified as a key phosphatase that counteracts Ypk1-medi-
ated phosphorylation of Orm proteins (5). This provides a
mechanistic basis for homeostatic regulation of sphingolipid
production and enables cells to respond rapidly to changing
environment (6). When SPT is inhibited by myriocin, a potent
inhibitor of SPT, yeast cells attempt to reinitiate sphingolipid
synthesis through activation of the Ypk1 kinase, which phos-
phorylates and inactivates Orm proteins, thereby leading to
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To induce disease in their hosts, many pathogens inject vir-
ulence proteins called effectors, which function inside the host
cells. Gram-negative bacteria, which are responsible for numer-
ous diseases in plants and animals, possess three different
syringe-like structures allowing injection of protein effectors
into the host cells: the type III, type IV, and type VI secretion
systems. Once inside host cells, the delivered effectors act as
virulence factors modulating cellular processes and suppress-
ing host defense for the benefit of the pathogen (7–9). The
study of effector proteins delivered by these specialized
machineries has provided remarkable insight not only into fun-
damental aspects of host-pathogen interactions but also into
the basic biology of eukaryotic cells. Notably, type III effectors
(T3Es) were shown to target components of the immune sys-
tem, transcription, cell death, proteasome and ubiquitination
systems, RNAmetabolism, hormone pathways, and chloroplast
and mitochondrion functions (10–12). A current challenge is
to systematically determine the virulence functions, biochemi-
cal activities, and host targets of bacterial effectors.
Recently, surrogate hosts like the yeast Saccharomyces
cerevisiae have become increasingly popular to study the func-
tion of effector proteins (13). This is based on the observation
that effectors often target fundamental cellular processes that
are conserved among eukaryotes. For example, a systematic
screen of the yeast deletion strain collection for strains hyper-
sensitive to the expression of the ShigellaT3EOspF identified a
role for this effector in innate immunity regulation (14).
The bacterium Erwinia amylovora is the causal agent of fire
blight disease of pear and apple trees (15). The ability of E.
amylovora to promote disease depends on a type III secretion
system and on a single injected T3E named DspA/E (16, 17).
DspA/E belongs to the AvrE effector family of T3Es, and func-
tional cross-complementation has been demonstrated between
DspA/E of E. amylovora and AvrE of Pseudomonas syringae or
WtsE of Pantoea stewartii subsp. stewartii (18, 19). T3Es of the
AvrE family are widespread in plant-pathogenic bacteria and
are among the few T3Es conserved in most analyzed bacterial
genomes, suggesting that they provide basic virulence function
(20, 21). They are important to promote bacterial growth fol-
lowing infection (17, 22–25) and to suppress callose deposition,
a plant basal defense reaction that strengthens the plant cell
wall (26, 27). Furthermore, when tested, their ectopic expres-
sion in plant and yeast is toxic (28–32). This indicates that they
likely target a cellular process that is conserved in eukaryotic
cells. However, effectors of the AvrE family are very large pro-
teins of unknown function, and their mode of action once
inside the plant cell remains unsolved. AvrE-like effectors are
particularly amenable to study in yeast because these effectors
are highly toxic when expressed in S. cerevisiae (30, 33).
Wepreviously reported that theT3EDspA/E induces growth
arrest and alters cellular trafficking in S. cerevisiae (33). To
unravel the cellular processes targeted by DspA/E, in this work
we performed a genetic screen to identify S. cerevisiaemutants
resistant to DspA/E-mediated growth arrest. The best suppres-
sors identified were mutants impaired in the sphingolipid bio-
synthetic pathway. Exogenously added sphingolipid precur-
sors, LCBs, also suppressed the DspA/E-mediated growth
defect. We further showed that expression of DspA/E led to a
decrease of LCB levels. This LCB depletion was due to down-
regulation of SPT activity. Interestingly, in contrast to the SPT
inhibitor myriocin, DspA/E expression did not activate the
Ypk1 kinase leading to hyperphosphorylation of Orm proteins
FIGURE1.Schematic viewof the sphingolipidmetabolism in S. cerevisiae.
Metabolic intermediates and complex sphingolipids are shown inbold; genes
are indicated in grayor red. The genes indicated in red correspond tomutants
resistant to DspA/E-mediated toxicity. Specific inhibitors of SPT (myriocin),
ceramide synthase (Fb1), and IPC synthase (AbA) are also indicated. Sphingo-
lipid biosynthesis starts in the endoplasmic reticulumwith the condensation
of serine and palmitoyl-CoA. This step is catalyzed by SPT to produce 3-keto-
dihydrosphingosine (KDS). Two related proteins, Lcb1 and Lcb2, het-
erodimerize to form the active SPT. A third protein, Tsc3, associates with the
Lcb1/Lcb2 heterodimer and stimulates SPT activity several fold, whereas
Orm1p and Orm2p proteins act as negative regulators of SPT. 3-Ketodihy-
drosphingosine is immediately reduced to DHS by an NADPH-dependent
reaction catalyzed by an enzyme encoded by the TSC10 gene. DHS can then
be hydroxylated by the Sur2 protein to give PHS. DHS and PHS are the yeast
LCBs that are amide-linked to a very long chain fatty acid by the ceramide
synthase to formceramides. Ceramide synthase activity requires either of two
redundant genes, LAC1 and LAG1. Ceramides are then modified in the Golgi
apparatus to form complex sphingolipids. The first modification is the addi-
tion of myoinositol phosphate to form inositol-phosphoceramide (IPC). This
reaction is catalyzed by IPC synthase whose activity requires the AUR1 gene.
IPC is then mannosylated to yield mannose-inositol-phosphoceramide
(MIPC), a reaction that requires theCSG1 andCSG2genes. The terminal step in
sphingolipid biosynthesis is the addition of inositol phosphate to MIPC to
yieldmannose-(inositol-P)2-phosphoceramide (M(IP)2C). The genes involved
in this last reaction are IPT1 and SKN1. FA, fatty acyl.
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but rather resulted in a dephosphorylation of Orm proteins via
a functional Cdc55-PP2A protein phosphatase.
EXPERIMENTAL PROCEDURES
Media, Bacteria, and Yeast Strains—The bacterial strain
used in this study was DH5-. Bacterial cells were grown in
Luria broth medium supplemented if required with 100
gml1 ampicillin. The wild-type yeast strain used for expres-
sion of DspA/E was BY4741 (MATa his31, leu20,met150,
ura30; designated as BY) obtained from Euroscarf. Pools of
the Euroscarfmutant library were kindly provided byAlain Jac-
quier (Pasteur Institute, Paris, France). Individual mutant
strains used in this study were ordered at Euroscarf. To main-
tain the plasmid expressing DspA/E (hereafter DspA/E) or the
pCMha189 empty vector (hereafter EV) (34), yeast cells
were routinely grown at 30 °C in selective synthetic complete
medium lacking uracil supplemented with 2% (w/v) glucose
(designated as SD-Ura). To repress DspA/E expression, doxy-
cycline (10 gml1) was added to the medium (designated as
SD-Ura Doxy).When required, SDmedium lacking both uracil
and histidine (SD-Ura-His) was used. For transformation, yeast
cells were grown overnight at 30 °C in YPD medium (1% (w/v)
yeast extract, 1% (w/v) Bacto Peptone, 2% (w/v) glucose) and
transformed with the appropriate plasmids selecting for proto-
trophy using the lithium acetate method.
Plasmid Construction—A fill-in was performed with T4
DNApolymerase on a DspA/E XbaI/SacI fragment issued from
pTB4 (28). This fragment was then cloned into the yeast cen-
tromeric URA plasmid pCMha189 (34) previously digested
with BamHI and filled with Klenow to give plasmid DspA/E.
Other plasmids used in this study are described in Table 1.
PCR Identification of the Yeast Deletion Mutants—For each
of the 14 pools initially identified in our screen, 30 independent
colonies grown on SD-Uramediumwere resuspended in 5l of
0.07 N NaOH and incubated for 5 min at 97.5 °C. This template
was then used for PCR amplification with two sets of primers:
U1 (5-GATGTCCACGAGGTCTCT-3) and KD1 (5-TC-
CTAACCTTTTATATTTCTC-3) or U2 (5-CGTACGCTG-
CAGGTCGAC-3) and KU2 (5-ATGGTATTGATAATCCT-
GATATG-3). The amplified products were then sequenced to
identify the 20-mer bar codes unique to each mutant.
Chemicals—6-Aminoquinolyl-N-hydroxysuccinimidyl car-
bamate reagent was purchased from Waters Corp. (Milford,
MA) as an AccQ Fluor reagent kit and dissolved according to
the manufacturer’s instructions. C16-SPH was purchased from
Matreya Inc. (Pleasant Gap, PA). Phytosphingosine (PHS) and
dihydrosphingosine (DHS) were purchased from Enzo Biomol
and dissolved in ethanol as 1 mgml1 stock solutions. Phos-
tagTM (Wako Chemicals) was prepared according to the man-
ufacturer’s instructions. For the thin-layer chromatography
(TLC), fumonisin B1 (Fb1) (Sigma-Aldrich) and aureobasidinA
(AbA) (Ozyme) were used at 100 gml1 (35) and 1 gml1
(36) concentrations, respectively. To induce Ypk1 kinase and
Orm protein hyperphosphorylation and activation, myriocin
(Sigma-Aldrich) was dissolved in 100% methanol to 500
gml1 and used at a final concentration of 0.5 gml1. The
following antibodies were used: anti-Ypk1 at 1:1000 (37),
monoclonal anti-Ypk1 Thr(P)-662 at 1:1000 (3) (kindly pro-
vided by R. Loewith), anti-FLAG at 1:1000 (M2, Sigma-Al-
drich), anti-HA at 1:1000 (Cell Signaling Technology), anti-ac-
tin at 1:2000 (Millipore), and the appropriate HRP-conjugated
anti-mouse IgG antibodies at 1:5000 (Pierce).
Free LCB Extraction—Strains were grown on SD-Ura Doxy
plates for 48 h. Then the yeast cells were diluted to anA600 of 0.7
in 100ml of SD-Ura and grown for 3 h to anA600 of 1. Cells were
washed three times with ice-cold water, and pellets were sus-
pended in 5 ml of methanol/chloroform (1:1) as described (38).
At this stage, 10 ng of C16-SPH/A600 unit were added to each
sample as a quantitative internal standard. Extraction was per-
formed twice in a 50 °C bath with frequent mixing. Pooled lipid
extracts were dried under nitrogen, desalted by butanol/water
partitioning, dried under nitrogen, and resuspended in metha-
nol. Then AccQ derivatization was done as described (39). Ali-
quots of derived lipids (20 l) were subjected to HPLC as
follows.
HPLCSeparation andAnalysis—Reversed phase chromatog-
raphy was carried out on a C18 column (100 4.6mm, C18, 100
Å, 2.6m,Kinetex Phenomenex) with a C18 guard column (4
3 mm, Gemini C18, 10/PK AFO-8497) on a Beckman Coulter
System Gold 126 liquid chromatograph with 32 Karat software
and with an RF-10A XL Shimadzu fluorescence detector. Elu-
tion was performed as described (39) except that elution was
carried out for 35 min isocratically at a 0.3 mlmin1 flow rate
with acetonitrile/methanol (60:40) (solvent A). At the end of
the run, the column was recycled using a 1-min linear gradient
from 100% solvent A to 100% acetonitrile (solvent B), 5 min of
solvent B at 0.5 mlmin1, 0.5-min linear gradient to solvent A
at 0.5 mlmin1, and 5-min equilibration with solvent A at 0.3
mlmin1. Elution of fluorescent compoundswasmonitored by
excitation at 244 nm and emission at 398 nm. The data pre-
sented are mean values of three independent experiments
Results are presented as means S.D. (n 3; ***, p	 0.001; **,
p	 0.05; *, p	 0.09; two-tailed Student’s t test).
Cell Labeling and Thin-layer Chromatography—Cells were
grown on SD-Ura Doxy plates for 48 h, diluted to anA600 of 0.7
in 10 ml of SD-Ura liquid medium, and grown for 90 min at
30 °C.When required, Fb1 andAbAwere added 30min prior to
labeling. Yeast cells were then labeled at 25 °C for 40 min by
adding 20 Ci of [14C]serine, diluted with 3 ml of fresh pre-
warmed SD-Ura medium, and further incubated for 80 min at
25 °C. Labeling was stopped by adding 40 l of 3 mM NaN3, 10
mM NaF. Cells were then washed with water twice, suspended
in methanol/chloroform (1:1), and disrupted with glass beads
by vortexing. After 5 min of centrifugation at 3000 rpm, the
TABLE 1
Plasmids used in this study
aa, amino acids.
Plasmids Description
Source/
Ref.
pDspA/E pCMha189::dspA/E (CEN URA, XbaI-SacI) This study
pRS413 Centromeric HIS vector This study
pMS062 pRS413::3xFLAG-ORM1 (CEN HIS, BamHI-EcoRI) This study
pMS005 pRS413::3xHA-ORM2 (CEN HIS, XbaI-SacI) 46
pMS064 pRS413::3xFLAG-ORM1-3A S51A,S52A,S53A (CEN
HIS)
This study
pMS040 pGEX-6P-1::ORM1 [ORF aa 1–82] (BamHI-EcoRI) 46
pMS042 pGEX-6P-1::ORM1 [ORF aa 1–82]
S51A,S52A,S53A (BamHI-EcoRI)
46
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supernatant was collected, and pellet was re-extracted twice
with chloroform/methanol/water (10:10:3). Pooled superna-
tantwere dried under nitrogen, and lipidswere then desalted by
butanol/water partitioning. Lipids were developed by ascend-
ing TLC using 0.2-mm TLC silica gel 60 with chloroform,
methanol, 2 M NH4OH (40:10:1) as solvent. Radioactivity was
detected and quantified using a Storm 840 (Amersham
Biosciences).
Actin Polarization State of Cells—Cells were grown to loga-
rithmic phase, fixed by addition of 37% formaldehyde to a final
concentration of 3.7%, and incubated for 30 min at room tem-
perature. Cells were washed twice with PBS containing 1
mgml1 BSA, and the cell pellet was resuspended in 25 l of
PBS containing 1 mgml1 BSA. Then 5 l of rhodamine-phal-
loidin (Molecular Probes; 3000 units/1.5 ml of MeOH) were
added. After 1 h of incubation at room temperature in the dark,
cells were washed three times and resuspended in 500l of PBS
containing 1 mgml1 BSA. The actin cytoskeleton was visual-
ized using an Axioplan 2 fluorescence microscope from Zeiss.
Quantification of polarized and depolarized cells was per-
formed as described previously (33). At least 100 cells were
counted for each condition.Data are presented asmeans S.D.
of three independent experiments (n  100; p 	 0.001; two-
tailed Student’s t test).
Phosphoaffinity Gel Electrophoresis—To examine the phos-
phorylation state of FLAG-Orm1 and HA-Orm2, cells were
grown for 6 h in SD-Ura-His medium and treated with 0.5
gml1 myriocin for 1 h when required. Cells were then har-
vested and resuspended in TBS lysis buffer containing 15%
glycerol, 0.5% Tween 20, 10 mM NaF, 10 mM NaN3, 10 mM,
p-nitrophenyl phosphate, 10 mM sodium pyrophosphate, and
10 mM glycerophosphate, 1 mM PMSF, and protease inhibitor
mixtures (EDTA-free Complete, Roche Applied Science). Cells
were broken by a FastPrep (45 s 5with 3-min intervals on ice)
at 4 °C, and cell debris were removed by centrifugation at 500
g for 10 min. 10 g of proteins were then loaded onto 7.5%
SDS-polyacrylamide gels containing 25 M Phos-tag acrylam-
ide and 10 MMnCl2. The gels were run at 70-V constant volt-
age for 2.5 h and rinsed twice for 5min in 1mMEDTA-contain-
ing transfer buffer and then twice for 5 min in transfer buffer
without EDTA before transfer onto nitrocellulose membrane.
Immunodetection was performed using the anti-FLAG, anti-
HA, and anti-actin antibodies described above. Gel to gel dif-
ferences in band patterns are due to variability in phosphoaffin-
ity gel resolution (2).
Ypk1 in Vitro Kinase Assay—Endogenous Ypk1 kinase was
immunoprecipitated from total yeast cell lysates (200 g) by
Ypk1 antibodies (37). When needed, cells were treated with 0.5
gml1 myriocin for 1 h. Recombinant Orm proteins (GST-
Orm1N1-82 and GST-Orm1N1-82-3A) were prepared as
described (30). The kinase reaction (final volume, 100 l) was
performed in kinase buffer (25 mM Tris-HCl (pH 7.5), 5 mM
-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM
MgCl2). Reactions were started by addition of 10 l of ATP
mixture (400 M ATP and 3 Ci of [-32P]ATP (Amersham
Biosciences)) and incubated for 30 min at 30 °C under vigorous
shaking. Reactions were stopped by adding 5 SDS-PAGE
sample buffer and incubated for 10 min at 65 °C. Proteins were
separated on two SDS-polyacrylamide gels. One gel was trans-
ferred to nitrocellulose membrane for Western blotting,
whereas the other gel was autoradiographed with an imaging
plate (Fujifilm), and the images were captured by a Typhoon
scanner (GE Healthcare).
Phosphorylation State of Ypk1 Kinase—Extracts were pre-
pared as described previously for FLAG-Orm1 and HA-Orm2.
Proteins were then resolved on a 7.5% phosphate affinity SDS-
polyacrylamide gel and blotted on nitrocellulose membrane.
Immunodetection was performed using anti-Ypk1Thr-662, anti-
Ypk1, and anti-actin antibodies described above.
RESULTS
YeastMutants Affected in the Sphingolipid Biosynthetic Path-
way Are Resistant to DspA/E-mediated Growth Defect—To
unravel the cellular processes targeted by DspA/E in yeast, the
DspA/E gene was cloned into the yeast centromeric plasmid
pCMha189, which contains a doxycycline-regulatable pro-
moter and URA3 as a selection marker (34). On SD-Ura
medium, growth of the BY strain transformed with plasmid
DspA/Ewas severely impaired, whereas growth of the BY strain
transformed with the EV was not altered. On SD-Ura Doxy
medium repressing DspA/E expression, the two strains grew
equally well (Fig. 2A). To identify mutants resistant to DspA/E,
we developed a screen based on transformation of strain BY
with the plasmid DspA/E. When we transformed the strain BY
with plasmid DspA/E and plated half of the transformed cells
on SD-Uramediumandhalf of the transformed cells on SD-Ura
Doxy medium, 2 days post-transformation the ratio of the
number of colonies on SD-Ura versus the number of colonies
on SD-Ura Doxy remained stable over 20 independent trans-
formations (0.007 0.002).We used this ratio to identify puta-
tive suppressors of the DspA/E-induced growth defect. Forty-
five pools of 100 mutants of the Yeast Knock-out deletion
collection (40, 41) were transformed with DspA/E. We rea-
soned that if a resistant mutant was present in a pool then the
ratio of colonies grown on SD-Ura versus colonies grown on
SD-Ura Doxy would be reproducibly higher than the ratio
observed with the wild-type strain BY. This was indeed the case
for 14 pools for which we observed a ratio above 0.03 2 days
post-transformation following three independent transforma-
tions. From these 14 pools, 10 colonies were randomly picked
from SD-Ura medium in each of the three independent trans-
formations and further analyzed to identify the corresponding
mutant. Sixty-three mutants, each found at least two times,
were ordered fromEuroscarf and transformed individuallywith
plasmid DspA/E. Among ninemutants having a ratio following
transformation superior to 0.5, six were affected in the sphin-
golipid biosynthetic pathway or in transport of metabolic
precursors of this pathway (YPL057C/CSG1, YDR072C/IPT1,
YDR497C/ITR1, YEL042W/GDA1, YDR372C/VPS74, and
YPL056C/LCL1; Fig. 2B in red and Fig. 1). Because our screen-
ing procedure was not exhaustive, we decided to transform the
available viable singlemutants of the sphingolipid pathwaywith
plasmid DspA/E. This allowed the identification of six new
mutants (YBR036C/CSG2, YGR143W/SKN1, YCR034W/
FEN1, YLR372W/SUR4, YGR038W/ORM1, YLR350W/ORM2,
andYBR161W/CSH1) for which the calculated ratio of colonies
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grown on SD-Ura/colonies grown on SD-Ura Doxy is above 0.4
(Fig. 2B in blue and Fig. 1). When plated on SD-Ura medium,
the 13 identified mutations were able to rescue the growth of
the yeast strain expressing DspA/E, confirming their suppres-
sor status (Fig. 2C).
Exogenous LCBs Suppress DspA/E-mediated Growth Defect—
We further investigated why mutations affecting the sphingo-
lipid biosynthetic pathway are suppressors of DspA/E-induced
growth arrest. Mutants blocked in complex sphingolipid bio-
synthesis downstream of SPT (ipt1, skn1, csg1, csg2, and
skn1) are known to accumulate precursors of the sphingolipid
pathway such as ceramides, LCBs, or LCB-Ps (42). Mutants
affected in acyl-CoA incorporation (sur4 and fen1) also
result in LCB accumulation (36, 43). Finally,mutants affected in
the regulation of SPT activity (orm1 andorm2) are no longer
able to down-regulate SPT activity, which leads to accumula-
tion of sphingolipid precursors (2). Overall, this suggests that a
high level of LCBs may suppress DspA/E-mediated effects. If
this is true, then exogenously added LCBs, which are rapidly
incorporated in ceramides and complex sphingolipids (36),
should also rescue the growth of yeast cells when DspA/E is
expressed. To test this hypothesis, we grew the BY DspA/E and
BY EV strains in the presence of 15 M PHS or 15 MDHS. On
SD-Ura medium, both LCBs at 15 M partially suppressed the
growth defect of strain BY DspA/E (Fig. 3). Interestingly, care-
ful observation of the growth assay showed that 15 M PHS or
15 M DHS was slightly toxic to BY EV yeast cells on medium
supplementedwith doxycycline, whereas growth of BYDspA/E
cells was not affected. This suggests that on repressive medium
DspA/E is not fully repressed and counteracts the toxicity
induced by LCB addition to the growth medium.
DspA/E Expression Is Associated with Decreased LCB Levels—
The above findings suggest that DspA/E-mediated toxicitymay
be linked to a decrease in LCB levels. To test this hypothesis, we
examined the LCB levels (DHS and PHS) in BY cells expressing
DspA/E. Because a dynamic balance exists between the LCBs
and their phosphorylated forms (Fig. 1), we also monitored the
levels of PHS-P and DHS-P. Overall, whatever the LCB species
examined (DHS, PHS, DHS-P, or PHS-P), the level observed in
BY DspA/E cells was lower than that observed in BY EV cells
(Fig. 4A).We then examined the levels of LCB and LCB-P in the
sur4 and fen1 cells with or without DspA/E. In sur4 cells
carrying the empty vector, very high levels of PHS, DHS-P, and
DHS were detected compared with those detected in BY EV
cells, whereas the DHS-P level was lower than that observed in
BY EV cells (Fig. 4B). In fen1 EV cells, the observed PHS-P,
PHS, DHS-P, and DHS levels were all higher than those
observed in BY EV cells and sur4 cells (Fig. 4D). These phe-
notypes are consistent with a previous publication (44). When
DspA/E was expressed in sur4 or fen1 cells, the levels of
LCBs and LCB-Ps were reduced compared with the control
sur4 EV or fen1 EV cells (Fig. 4, B, C, and D). In sur4
DspA/E cells, the levels of LCBs and DHS-P were similar to
those observed in the BY EV cells, whereas the PHS-P level was
lower (Fig. 4,B andD). Infen1DspA/E cells, the levels of LCBs
and DHS-P remained higher than those observed in the BY EV
cells, whereas the PHS-P level was similar (Fig. 4, C and D).
Altogether, these results indicate that DspA/E expression
induces LCBs and LCB-P depletion in BY, sur4, and fen1
cells. However, in the suppressor mutants sur4 and fen1,
LCB levels were maintained at the same or above the level
observed in BY EV cells.
DspA/E Expression Alters Sphingolipid Biosynthesis—DspA/
E-induced LCB depletion suggests that the expression of
FIGURE 2. Sphingolipidmutants are suppressors ofDspA/E-inducedgrowthdefect.A, serial dilutions of strain BYDspA/E or BY EVwere spotted on SD-Ura
Doxy or SD-Ura plates. Photographs were taken after 48 h growth. B, ratio of the number of colonies (Col.) observed on SD-Ura medium versus the number of
colonies observed on SD-Ura Doxy medium for the indicated yeast strains transformed with DspA/E. The red bars represent the ratio observed with the yeast
mutant strains identified through the general screeningprocedure,whereas the blue bars represent the ratio observedwith the yeastmutant strains identified
through systematic analysis of available viable single mutants of the sphingolipid pathway. C, serial dilutions of the indicated strains bearing plasmid DspA/E
spotted on SD-Ura Doxy or SD-Ura. All photographs were taken after 48 h of growth.
FIGURE 3. Exogenously added LCBs rescue DspA/E-mediated growth
defect. Serial dilutions of strain BY DspA/E or BY EV were spotted on SD-Ura
Doxy or SD-Ura plates supplemented or not with 15 M DHS or 15 M PHS.
Photographs were taken after 48 h of growth.
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DspA/E represses LCB synthesis. To examine this hypothesis,
we performed in vivo metabolic labeling with [14C]serine of
neosynthesized LCBs in yeast cells containing either the empty
vector or plasmid DspA/E. As a control, wemonitored the LCB
level in the presence ofAbA and Fb1, inhibitors of inositolphos-
phoceramide (IPC) synthesis and ceramide synthesis, respec-
tively (Fig. 1). As expected, in BY EV cells, AbA caused cer-
amide accumulation (Fig. 5, A and C). Surprisingly, we also
observed an LCB decrease in the presence of AbA, which could
be interpreted as an attempt of the cell to overcome the inhibi-
tion of IPC synthesis by overproduction of ceramides (Fig. 5, A
and B). The presence of Fb1, which blocks ceramide synthesis,
caused a ceramide decrease and LCB accumulation as expected
(Fig. 5, A, B, and C). Conversely, an uncharacterized lipid a
characteristic of ceramide synthesis inhibition (36) and another
uncharacterized lipid (denoted §) already observed in sphingo-
lipid TLC profiles (45) appeared (Fig. 5A). Upon DspA/E
expression, the amount of LCB observed was always reduced
compared with the empty vector treatment (Fig. 5, A and B).
The expression of DspA/E also counteracted the elevation of
ceramides observed in the presence of AbA (Fig. 5, A and C),
further indicating that the LCB decrease observed upon
DspA/E expression cannot be explained by an accumulation of
ceramides. Interestingly, a mild base-resistant uncharacterized
lipid (denoted * in Fig. 5A) also appeared in cells expressing
DspA/E.We could not detect this additional species inHPLC. It
is therefore unlikely that this band could be 3-ketodihydrosph-
ingosine. As a control, we also measured the uptake of [3H]ser-
ine by both BY EV and BY DspA/E cells and observed that
expression of DspA/E in yeast did not affect the uptake (Fig.
5D). Altogether, these results indicate that LCB neosynthesis is
reduced upon DspA/E expression. This reduction could be
attributed to down-regulation of either Tsc10p or SPT activity
(Fig. 1). However, because we could not detect 3-ketodihy-
drosphingosine accumulation, the reduction of LCB neosyn-
thesis following DspA/E expression is likely due to down-regu-
lation of SPT activity.
The sur4 and fen1 Mutants Restore Polarization of Actin
Affected by DspA/E—In a previous study, we showed that the
expression of DspA/E in yeast strongly affects the polarization
of actin (33). This prompted us to examine whether the sur4
and fen1 mutants could also restore the polarization of actin
affected byDspA/E. To test this hypothesis, cells were grown to
exponential phase, and the actin cytoskeleton was visualized
using rhodamine-phalloidin. We observed 
75% polarized
cells for the control strain BY EV (Fig. 6). When DspA/E was
expressed, the strain BY DspA/E became depolarized as previ-
ously observed and contained only 20% polarized cells (Fig. 6).
However, when DspA/E was expressed in sur4 or fen1 cells,
we observed 58 and 82% polarized cells, respectively (Fig. 6).
Based on these results, we conclude that the sur4 and fen1
mutations suppress the actin polarization defect observed inBY
yeast cells following DspA/E expression.
DspA/E Expression Induces Dephosphorylation of Orm
Proteins—We next wondered how expression of DspA/E leads
to SPTdown-regulation. In yeast,Orm1 andOrm2 are dynamic
negative regulators of SPT that are regulated by phosphoryla-
tion. We therefore tested whether DspA/E expression influ-
ences the phosphorylation status of Orm proteins. To test this,
DspA/E was co-expressed in yeast cells with FLAG-Orm1 or
HA-Orm2, and the phosphorylation status of both Orm pro-
teins was checked by electrophoresis in SDS-polyacrylamide
gels that incorporate a phosphate binding agent to improve the
separation of phosphorylated species (Phos-tag). FLAG-Orm1
FIGURE 4.DspA/E-mediatedgrowthdefect is associatedwithdepletionof LCB levels.A, histogram representing LCB (DHS andPHS) and LCB-P (DHS-P and
PHS-P) levels observed in lipid extracts derived from BY EV or BY DspA/E cells 3 h after a shift from SD-Ura Doxy medium to SD-Ura medium. Quantities were
calculated usingC16-SPH as an internal standard. B andC, histograms representing LCB (DHS andPHS) and LCB-P (DHS-P andPHS-P) levels observed in extracts
derived from BY DspA/E, sur4 EV, and sur4 DspA/E cells (B) and from BY DspA/E, fen1 EV, and fen1 DspA/E cells (C) 3 h after a shift from SD-Ura Doxy
mediumtoSD-Uramedium. InB andC, results are expressedas -fold change (FC) comparedwith theBYEV control. InA,B, andC, results arepresentedasmeans,
and error bars represent S.D. (n 3; ***, p	 0.001; **, p	 0.05; *, p	 0.09; N.S, non-significant; two-tailed Student’s t test). D, LCB and LCB-P levels observed
(pmolA600
1) for the above strains presented as means S.D.
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andHA-Orm2 appeared asmultiple phosphorylated forms that
collapsed to faster migrating species upon DspA/E expression,
indicating that DspA/E expression decreased the phosphoryla-
tion status of Orm proteins (Fig. 7, A and B). Conversely, upon
addition of the SPT inhibitormyriocin to BY cells, FLAG-Orm1
appeared hyperphosphorylated (Fig. 7A). As already described,
this is an attempt for cells to restore a correct intracellular level
of sphingolipids (4). Therefore, although both myriocin and
DspA/E repress SPT activity, their mode of action is different.
DspA/E-mediated Dephosphorylation of Orm Proteins
Requires the Cdc55-PP2APhosphatase—To regulate SPT activ-
ity, phosphorylation status ofOrmproteins is itself regulated by
the Ypk1 kinase and the PP2A phosphatase (3–5). Two groups
of phosphorylation sites have been described on Orm1. The
first is exclusively phosphorylated by the Ypk1 kinase at serines
51, 52, and 53 and has been described as important for SPT
activity (4), whereas the second (serines 29, 32, 34, 35, and 36) is
not involved in this regulation (46). To examine whether
DspA/E affects the phosphorylation triggered by Ypk1, we
checked the phosphorylation status of the FLAG-Orm1-WT
and FLAG-Orm1-3A devoid of the Ypk1 phosphorylation site
(serines 51, 52, and 53) in BY DspA/E and BY EV cells. The
expression of DspA/E had only a slight impact on the phosphor-
ylation status of FLAG-Orm1-3A, indicating that expression of
DspA/E mostly impacts phosphorylation of the Ypk1 site (Fig.
7A). We therefore examined the impact of DspA/E expression
FIGURE 5.DspA/E expression alters sphingolipid biosynthesis. A, TLC analysis of [14C]serine-labeled sphingolipids. 10 A600 units of BY cells harboring EV or
expressing DspA/E were grown on SD-Uramedium supplemented or not with ceramide synthase inhibitor (Fb1; 100gml1) or IPC synthase inhibitor (AbA;
1 gml1) before labeling. Lipids were extracted, O-deacetylated by NaOH treatment, and resolved by TLC in chloroform/methanol/NH4OH (40:10:1, v/v/v).
Radiolabeled sphingolipids were revealed and quantified using a Storm phosphorimaging system. The same amount of cells (2.5 A600 units) was spotted for
each sample. Assignments are supported by (I) the accumulation or absence of major bands upon specific inhibitor treatments, (II) comparison with cold PHS
and DHS standards revealed by nihydrin and (iii) previous report (36, 45). Cer, ceramide; a, lipid a (36); §, uncharacterized Fb1-induced lipid (45); *, uncharac-
terized DspA/E-induced lipid; o, origin. The image presented is representative of three independent repetitions. B and C represent the quantification of LCBs
and ceramides, respectively, shown in A in band intensity103. D, serine uptake assay in BY EV and BY DspA/E cells. Cells were labeled with [3H]serine, and
incorporation of [3H]serine was measured by a scintillation counter. Results are represented as means, and error bars represent S.D. (n 3; p 0.1; n.s, not
significant; two-tailed Student’s t test).
FIGURE 6. The sur4 and fen1 mutants restore actin polarization
affected by DspA/E. Strains were grown in selective medium (SD-Ura) at
30 °C to exponential phase. Actin structure was then visualized using rhod-
amine-phalloidin and fluorescence microscopy. The histogram shows the
average percentage of polarized cells versus the total number of cells. At least
100 cells were counted for each condition. Data are presented as means of
three independent experiments, and conditions with different letters are sta-
tistically different (n 100; p	 0.001; two-tailed Student’s t test). Error bars
represent S.D.
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on Ypk1 activity both in vitro and in vivo. Ypk1 was immuno-
precipitated fromyeast cells expressingDspA/E and assayed for
kinase activity using wild-type GST-Orm1N1–82 protein (Fig.
7C,WT) as a substrate in vitro. We also used GST-Orm1N1–82-3A
phosphodeficient protein (Fig. 7C, 3A) devoid of Ypk1 phos-
phorylation sites as a control substrate. GST-Orm1N1–82 wild-
type protein was phosphorylated to the same extent by Ypk1
immunopurified from either BY DspA/E or BY EV cells,
whereas no phosphorylation was detected with the GST-
Orm1N1–82-3A protein (Fig. 7C). As a control, we checked
GST-Orm1N1–82 hyperphosphorylation by Ypk1 purified from
myriocin-treated BY EV cells (Fig. 7D).We further checked the
phosphorylation status of Ypk1 followingDspA/E expression in
vivo using an antibody specifically raised against the phospho-
rylated Thr-662 residue of Ypk1 (3). Although an increased
level of Ypk1Thr-662 phosphorylation was observed with the
myriocin-treated control, expression of DspA/E did not affect
Ypk1Thr-662 phosphorylation (Fig. 7E). Therefore, expression of
FIGURE 7. DspA/E expression induces dephosphorylation of Orm proteins without affecting Ypk1 activity. A, FLAG-Orm1 or FLAG-Orm1-3A proteins
were expressed inwild-type BY cells harboringDspA/E or the EV. After 6 h on SD-Ura-Hismedium, the cellswere lysed, and the resulting extractswere resolved
byphosphate affinity SDS-PAGE (Phos-tag) gels andanalyzedby immunoblottingwith anti-FLAG. Loading controls on SDS-polyacrylamidegelswere analyzed
by anti-FLAG and anti-actin antibodies. As a control, myriocin-treated and untreated BY (EV) cells are shown. B, HA-Orm2 was expressed in wild-type BY cells
harboring DspA/E or the EV and analyzed by anti-HA or anti-actin antibody. C, Ypk1 was immunopurified from BY yeast cells harboring DspA/E or EV, and its
ability to phosphorylate wild-type GST-Orm1N1–82 protein (WT) or the GST-Orm1N1–82-3A phosphodeficient protein (3A) was tested. Controls of input Ypk1,
wild-typeGST-Orm1N1–82, andGST-Orm1N1–82-3A are shownbelow.D, Ypk1was immunopurified fromBYmyriocin-treatedor untreated cells, and its ability to
phosphorylatewild-typeGST-Orm1N1–82was tested. Controls of inputYpk1andwild-typeGST-Orm1N1–82 are shownbelow. E, Ypk1phosphorylation statewas
checked in vivo by using an antibody that specifically recognized phosphorylation of Thr-662 of Ypk1 (Ypk1T662). Two exposures, short (S.E) and long (L.E), are
shown. Loading controls were analyzed by anti-Ypk1 and anti-actin antibody. BY cells harboring DspA/E or the EV are shown. Controls of myriocin-treated or
solvent-treated (MeOH) BY cells are also shown.
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DspA/E, contrary to treatment withmyriocin, does not activate
Ypk1.
We then tested whether DspA/E-induced Orm dephosphor-
ylation requires the PP2A phosphatase. PP2A is a heterotrim-
eric enzyme composed of three distinct subunits: a scaffold sub-
unit, a catalytic subunit, and a regulatory subunit encoded by
two distinct genes, CDC55 and RTS1 (47). Stability of the het-
erotrimeric complex requires a methylation of the C terminus
of the catalytic subunit by the carboxymethyltransferase Ppm1
protein (48, 49). Interestingly, we identified ppm1 in our
screen as a good suppressor of DspA/E-mediated growth arrest
(Fig. 8A). Amajor function of the regulatory subunit is to target
substrate phosphoproteins to the PP2A phosphatase (47). Orm
proteins were described as hyperphosphorylated in a cdc55
mutant, whereas their phosphorylation status was notmodified
in a rts1mutant, indicating that Cdc55 is the only PP2A reg-
ulatory subunit involved in Orm-dependent sphingolipid regu-
lation (5). We therefore checked suppression of DspA/E-medi-
ated growth arrest in a cdc55 mutant (Fig. 8A) and compared
the phosphorylation status of FLAG-Orm1 protein upon
DspA/E expression in either cdc55 or BY cells (Fig. 8B). Con-
trol myriocin-treated cdc55 and BY cells showed hyperphos-
phorylation of FLAG-Orm1. As already observed in Fig. 6A,
DspA/E expression had a severe impact on FLAG-Orm1 phos-
phorylation in BY cells; however, in cdc55 cells, FLAG-Orm1
phosphorylation remained mostly unchanged (Fig. 8B). This
indicates that DspA/E-mediated dephosphorylation of Orm
proteins requires a functional Cdc55-PP2A phosphatase.
DISCUSSION
To unravel the mode of action of the bacterial effector
DspA/E, we performed a genetic screen and identified several S.
cerevisiaemutants resistant to DspA/E-induced growth arrest.
Our screen, based on transformation efficiency on inducing
medium relative to the repressive medium, was simple, effi-
cient, and particularly suited to study highly toxic effectors.
Furthermore, it allowed the classification of suppressor
strength, a feat not possible using a simple serial dilution plate
assay (Fig. 2, compare B and C).
Using this screen, we discovered that mutants affected in the
sphingolipid biosynthesis pathway are the most resistant to the
DspA/E-induced growth defect. Further analysis showed that
expression of DspA/E decreased LCB levels both in wild type
and sphingolipid mutants. However, in the sphingolipid
mutants, LCB levels were maintained at the same or above the
level observed in the wild-type strain when DspA/E was
expressed. Interestingly, fen1, the best suppressor identified
in our screening procedure (Fig. 1B), also showed very high
intracellular LCB levels (Fig. 4D). Exogenously added LCBs also
partially suppressed theDspA/E-mediated growth defect. Alto-
gether, these results indicate that when LCB levels are main-
tained above the threshold observed in the wild-type yeast
strain cell growth is possible, whereas below this threshold, cell
growth is stopped. This highlights the importance of LCB levels
in DspA/E-induced growth arrest.
We previously described that expression of DspA/E in S.
cerevisiae impairs endocytosis and actin polarization (33). This
alteration of cellular trafficking can now be attributed to SPT
repression and LCB depletion because we showed in this work
that the sur4 and fen1 mutations, for which LCB levels are
maintained at the same or above the level observed in the wild-
type strain expressing DspA/E, suppressed the DspA/E-in-
duced actin polarization defect. Our results are consistent with
a previous study showing that repression of SPT activity,
induced at 37 °C with the lcb1-100 thermosensitive mutation,
blocks LCB synthesis and impairs endocytosis and actin orga-
nization (50).
SPT repression is not directly driven byDspA/E, andwe have
shown that DspA/E expression led to dephosphorylation and
activation of Orm proteins, the negative regulators of SPT.
Interestingly, myriocin, a direct inhibitor of SPT, has an oppo-
site effect on Orm phosphorylation. Myriocin induces Ypk1-
mediated hyperphosphorylation and inactivation of Orm pro-
teins (2). This is an attempt of the cell to restore sphingolipid
production. Contrarily, DspA/E, by decreasingOrm phosphor-
ylation, prevents any attempt of the yeast cell to restore sphin-
golipid production.
The phosphorylation status of Orm proteins is driven by the
Ypk1 kinase and the Cdc55-PP2A phosphatase (4, 5). We
showed that, upon DspA/E expression, Ypk1 activity was not
FIGURE 8.DspA/E-induced growth arrest andOrmprotein dephosphory-
lation require a functional Cdc55-PP2A phosphatase. A, serial dilutions of
strains BY, ppm1, and cdc55 harboring DspA/E or the EV were spotted on
SD-Ura Doxy or SD-Ura plates. Photographs were taken after 48 h of growth.
B, FLAG-Orm1 was expressed in BY and cdc55 mutant cells expressing
DspA/E or not (EV). After 6 h on SD-Uramedium, the cells were lysed, and the
resulting extracts were resolved by Phos-tag gels and analyzed by immuno-
blotting with anti-FLAG. Loading controls on SDS-polyacrylamide gels were
analyzed by anti-FLAG or anti-actin antibodies. Controls of BY and cdc55
mutant treated with myriocin are also shown.
A Type III Effector Mediates Repression of LCB Synthesis
18474 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 26•JUNE 27, 2014
 at U
niversitaetsbibliothek M
edizin on N
ovem
ber 8, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
affected, suggesting that Orm dephosphorylation is mainly
driven by the Cdc55-PP2A phosphatase. Actually, we observed
that the cdc55 mutation affecting the regulatory unit of the
Cdc55-PP2A phosphatase suppressed DspA/E-mediated
growth arrest and dephosphorylation of Orm proteins. This
confirms that DspA/E-mediated effects require the Cdc55-
PP2A phosphatase. At this stage, we cannot determine whether
DspA/E directly activates Cdc55-PP2A. A previous study also
proposed the Cdc55-PP2A phosphatase to be involved in sph-
ingolipid synthesis repression (5), but it is currently unknown
how Cdc55-PP2A is activated.
Overall, our results led to the following model explaining
DspA/E toxicity (Fig. 9). DspA/E-mediated growth arrest
requires a functional Cdc55-PP2A phosphatase, which drives
Orm dephosphorylation, thereby resulting in SPT repression
and LCB depletion, which lead to the observed toxicity. This is
a new way for a bacterial effector to perturb the eukaryotic cell.
The sphingolipid pathway was shown previously to be per-
turbed by several plant fungal pathogens producingmycotoxins
such as Fb1 andAlternaria alternata f. sp. lycopersici toxin that
competitively inhibit ceramide biosynthesis (51, 52), but until
now, this pathway was not described as being perturbed by
plant bacterial pathogens. As DspA/E belongs to a widespread
family of T3Es conserved in plant-pathogenic bacteria (53), the
mode of action that we unraveled in this work is likely impor-
tant for most plant-bacterium interactions.
The sphingolipid biosynthetic pathway is highly conserved in
all eukaryotes. In particular,ORM genes are evolutionarily con-
served, and ORM homologs At1G01230 and At5G42000 are
found in the genome of the model plant Arabidopsis thaliana
(54). It is therefore likely that Orm proteins function similarly
in plants as key regulator of sphingolipid homeostasis. Hence, it
has been reported in several plant-pathogen interactions that
the sphingolipid biosynthetic pathway is induced during the
hypersensitive response, an immunity-related form of pro-
grammed cell death that blocks pathogen attack at the site of
infection (54). Interestingly, induction of SPT and accumula-
tion of LCBs in planta during the early stage of the hypersensi-
tive response has been reported and linked to plant cell death
(55–57). Therefore, inhibition of SPT could be seen as a mech-
anism that delays hypersensitive response cell death and allows
bacterial development in planta. As observed in yeast, pertur-
bation of sphingolipid metabolism is also deleterious to plant
vesicular trafficking (58, 59). This may explain why DspA/E,
following infection, is required to block basal defense, which
require active cellular traffic, such as callose deposition at the
cell wall surface (26, 28). Perturbation of the sphingolipid path-
way could also explainwhyDspA/E induces plant cell death (28,
30, 32) because inhibition of the sphingolipid pathway ulti-
mately leads to plant cell death (60–62). Our results in yeast
pave the way for future plant studies.
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